Weeks after being arrested on charges of security fraud, Martin Shkreli, a Wall Street tycoon who gained notoriety for buying the rights of drugs and then dramatically raising their prices, received a subpoena to appear before a Congressional committee investigating price gouging in the pharmaceutical industry.

The House Committee on Oversight and Government Reform delivered a subpoena to Shkreli's attorneys, demanding his presence at a hearing on Tuesday, the New York Times reports.

The brash executive responded to the subpoena with characteristic nonchalance on Twitter:

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Employer-Paid